TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Novo Nordisk Pharmatech A/S
Closing information (x1000 DKK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 598,265 | 619,083 | 667,729 |
Earnings before taxes | 49,255 | 146,708 | 146,169 |
Total assets | 966,914 | 639,924 | 745,525 |
Current assets | 503,716 | 247,023 | 381,220 |
Current liabilities | 234,231 | 90,539 | 108,621 |
Equity capital | 689,619 | 520,247 | 606,434 |
- share capital | 10,001 | 10,000 | 10,000 |
Employees (average) | 150 | 150 | 150 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 71.3% | 81.3% | 81.3% |
Turnover per employee | 3,988 | 4,127 | 4,452 |
Profit as a percentage of turnover | 8.2% | 23.7% | 21.9% |
Return on assets (ROA) | |||
Current ratio | 215.1% | 272.8% | 351.0% |
Return on equity (ROE) | 7.1% | 28.2% | 24.1% |
Change turnover | -20,818 | -48,646 | 46,737 |
Change turnover % | -3% | -7% | 8% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.